GI Chair Lopa Mishra to leave MD Anderson Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

LOPA MISHRA has decided to leave MD Anderson Cancer Center, effective Aug. 31.

Mishra joined MD Anderson in December 2009 as professor and chair of Gastroenterology, Hepatology and Nutrition. In 2010, she was named holder of the Del & Dennis McCarthy Distinguished Professorship. Mishra also serves as associate director of the Texas Digestive Diseases Center.

During Mishra’s tenure, the department grew from one clinical program to eight programs in GI cancers.

In 2013, Gastrointestinal Cancer Program was awarded an “exceptional-outstanding” score by NCI as part of MD Anderson’s cancer center support grant. Mishra also initiated the first MD Anderson Global Academic Program with sub-Saharan Africa, including Ethiopia, Kenya and South Africa.

Mishra’s research has focused on targeting liver and GI cancers using the TGF-beta signaling pathway and stem-like tumor initiating cells. Using mouse and human genetic studies, her team identified a group of liver and GI stem cell proteins crucial for TGF-beta signaling and modulation of human GI cancers and Beckwith-Wiedemann Syndrome. Studies have yielded insights into the origins of hepatocellular carcinoma, 40 percent of which are clonal and could arise from STICs. Her research has led to more than 80 original articles in peer-reviewed journals.

Mishra has received many honors including: American Gastroenterological Association Award for Top Women in Gastroenterology (2008), Funderburg Scholar in Gastric Cancer (2003-05), Betty and Harry Myerberg Award for Excellence in Research in Liver Development (1998), Elisabeth and John Cox Award for Innovative Clinical Therapy of Esophageal Cancer (1996), USV Industry New Investigator Award (1995) and the Stuart Mill Prize in Tropical Medicine (1981).

Marta Davila will serve as chair ad interim.

Davila earned her medical degree from Harvard and completed her residency in Internal Medicine and Fellowship in Gastroenterology at the University of California, San Francisco. Her first faculty appointment was as assistant professor at Stanford Medical School.

She joined MD Anderson in 2004 as associate professor, and was promoted to professor in 2010. In 2014 Davila was named medical director of endoscopy. From 2007 to 2009, she served as interim deputy chair.

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login